Cordyceps Sinensis
Cordyceps Sinensis (Ophiocordyceps sinensis)
Cordyceps sinensis (Ophiocordyceps sinensis) is a parasitic fungus native to the high-altitude grasslands of the Tibetan Plateau and Himalayas, killing moth caterpillars to produce its fruiting body. It is the most expensive fungal commodity in the world, trading above $60,000 per kilogram at peak prices. For over 600 years it has been central to Tibetan and Chinese medicine — and to this day, virtually every supplement sold under its name contains a different organism entirely.
Ophiocordyceps sinensis (Berk.) G.H.Sung, J.M.Sung, Hywel-Jones & Spatafora (2007) — Family Ophiocordycipitaceae — Order Hypocreales
Cordyceps sinensis — correctly classified as Ophiocordyceps sinensis since 2007 — is one of the most scientifically complex, commercially significant, and widely misrepresented organisms in mycology. A single wild specimen consists of two parts fused together: the mummified body of a ghost moth larva that the fungus killed underground, and a slender dark stroma that erupts from the larva's head each spring. That combined structure, harvested by hand above 4,000 meters in the Himalayas, is the raw material behind a global trade in which wild specimens command prices that exceed gold by weight.
What Is Cordyceps Sinensis (Ophiocordyceps sinensis)?
Ophiocordyceps sinensis is an obligate entomopathogenic fungus — meaning it can only complete its life cycle by infecting and killing a living insect host. The host is a caterpillar: specifically the underground-living larvae of ghost moths in the family Hepialidae, primarily genera Thitarodes and Hepialiscus. The larvae live 3–5 years below the surface of alpine meadows, feeding on plant roots, before the fungus claims them.
What reaches the market is not a conventional mushroom. There are no gills, no cap, no spore print. The commercial specimen is a two-part composite: the sclerotium (the caterpillar's cuticle packed with fungal mycelium, brown, 3–5 cm long) attached to the stroma (the fruiting body that grows from the larva's head, dark brown to black, 4–10 cm tall). TCM literature calls the winter caterpillar form "winter worm" and the spring stroma "summer grass" — hence the Tibetan name yartsa gunbu, meaning "summer grass, winter worm."
One critical fact separates O. sinensis from virtually every other species in this guide series: it cannot be cultivated to produce fruiting bodies without a living caterpillar host. The mycelium can be grown in agar or liquid culture, and the strain sold commercially under the CS4 designation can be fermented at scale — but that strain is not O. sinensis at all. It is Samsoniella hepiali, a fungus in a different family, reclassified from its former name Paecilomyces hepiali. Nearly all clinical research, all commercial supplements, and the Out-Grow CS4 liquid culture are based on this organism. The distinction matters and is explained in full in the Cultivation and Chemistry sections below.
The species sits at the intersection of three disciplines that rarely overlap: high-altitude ecology, traditional Tibetan and Chinese medicine (where it has been documented since at least the 15th century), and modern pharmaceutical research. The most studied compounds in the supplement market — adenosine, polysaccharides, and the nucleoside cordycepin — behave very differently across wild specimens, CS4 fermentation products, and the related species Cordyceps militaris. This guide explains those distinctions with the level of precision the topic demands.
Interested in this species? Out-Grow carries a liquid culture.
Cordyceps Sinensis (Ophiocordyceps sinensis) Liquid CultureHow Is Cordyceps Sinensis (Ophiocordyceps sinensis) Classified?
| Rank | Taxon |
|---|---|
| Domain | Eukaryota |
| Kingdom | Fungi |
| Phylum | Ascomycota |
| Class | Sordariomycetes |
| Order | Hypocreales |
| Family | Ophiocordycipitaceae |
| Genus | Ophiocordyceps |
| Species | O. sinensis |
The current accepted name — Ophiocordyceps sinensis (Berk.) G.H.Sung, J.M.Sung, Hywel-Jones & Spatafora (2007) — results from a major phylogenetic revision. MycoBank ID: 504340. NCBI Taxonomy ID: 72228.
Synonym History
| Synonym | Authority & Year | Why It Exists |
|---|---|---|
| Sphaeria sinensis | Berk. 1843 | Basionym; original description before genus was understood |
| Torrubia sinensis | (Berk.) Tul. & C.Tul. 1865 | Reclassified to early entomopathogenic fungus genus |
| Cordyceps sinensis | (Berk.) Sacc. 1878 | Accepted name for ~130 years; still used in all commerce and most clinical literature |
| Hirsutella sinensis | X.J.Liu, Y.L.Guo et al. 1989 | The asexual (mycelial) anamorph stage; most accepted anamorph name in current literature |
The 2007 reclassification established the family Ophiocordycipitaceae and separated insect-pathogenic species from plant-associated Cordyceps sensu stricto, based on multi-gene molecular phylogenetics. Commercial products, clinical trial literature, and the Chinese Pharmacopoeia continue to use the legacy name Cordyceps sinensis and are expected to do so indefinitely.
How Do You Identify Cordyceps Sinensis (Ophiocordyceps sinensis)?
O. sinensis is unusual in that field identification requires finding the complete two-part specimen: the intact caterpillar body with the stroma still attached. The stroma alone, or the caterpillar body alone, is insufficient for confident ID without molecular confirmation.
Morphology
Being an ascomycete, O. sinensis produces no spore print and has no gills, cap, or basidia. Microscopic confirmation requires observing the filiform, multiseptate, articulated ascospores discharged in chains from the cylindrical asci.
Lookalike Species
Cordyceps militaris
The most commonly conflated species in the supplement market. Distinguished immediately by its bright orange-to-orange-red stroma color, superficial perithecia, and association with moth and butterfly pupae at montane to lowland elevations. Contains up to 90× more cordycepin than O. sinensis. Very different chemistry, very different cultivation biology.
Other Ophiocordyceps spp.
Multiple undescribed or cryptic Ophiocordyceps species occur at high elevations in the Himalayan range. Some specimens sold in regional markets may represent other species. ITS barcoding alone is insufficient to distinguish all congeners; multi-locus sequencing is required for reliable identification.
Samsoniella hepiali (CS4)
The organism in virtually all commercial "Cordyceps sinensis" products. Visually indistinguishable in fermented supplement form. A 2024 market survey estimated that over 70% of "sinensis" supplements misrepresent species content. Adenosine and polysaccharide profiles are similar; cordycepin and sterol profiles differ significantly.
Where Does Cordyceps Sinensis (Ophiocordyceps sinensis) Grow?
O. sinensis is an obligate entomopathogen — it has no saprotrophic stage and cannot grow on dead organic matter in the wild. It requires a living Thitarodes or Hepialiscus ghost moth larva at 3,000–5,000 m elevation in Kobresia sedge-grass alpine tundra. The fungus infects larvae when ascospores or conidia contact the host cuticle, penetrating within 4 days and colonizing the hemocoel over months.
| Country / Region | Key Areas | Notes |
|---|---|---|
| China (91.9% global supply) | Tibet, Qinghai, Sichuan, Yunnan, Gansu | Tibet + Qinghai + Sichuan = >82% of production |
| India | Sikkim, Arunachal Pradesh, Uttarakhand | Himalayan foothills above 4,000 m |
| Nepal | High Himalayan districts | Yarshagumba collection is a major rural livelihood; ~95% of harvesters report declining availability |
| Bhutan | Gasa, Bumthang, Lhuentse districts | Harvesting legalized in 2004; auction prices up to ~$26,520 USD/kg |
| Not found | Africa, the Americas, Europe, non-Himalayan Asia | Range is strictly defined by host and elevation |
Life Cycle and Seasonality
| Stage | Timing | Notes |
|---|---|---|
| Ascospore dispersal | Late spring (May–June) | Filiform spores ejected into air or deposited in soil |
| Host larval infection | July–late August | Conidia adhere to cuticle within 2 days; penetrate within 4 days; blastospores in hemocoel within 6 days |
| Internal development | Late summer–autumn–winter | Blastospores persist 5+ months; mycelium colonizes host progressively; host behaves abnormally in late stages |
| Mummification | Autumn–early winter | Host dies; body packed with mycelium (sclerotium) |
| Dormancy | Winter | Sclerotium frozen under snow |
| Stroma emergence | March–April | Stroma erupts from head of larva and elongates rapidly |
| Harvest window | May–July | Collected before ascospores are released to preserve value |
Conservation Status
The species is listed as Vulnerable on the IUCN Red List (criteria A2bcd+3bcd+4bcd), with population estimated to have declined more than 30% in the past 15 years. China classified it as a Class II endangered species in 1999. Primary threats include over-harvesting (pre-spore collection is especially damaging), habitat trampling, and climate change — which is shifting suitable habitat upward by 500–1,000 m and may reduce net habitat by up to 36–39% under high-emissions scenarios by 2070.
Can You Cultivate Cordyceps Sinensis (Ophiocordyceps sinensis)?
Why True Fruiting Body Production Is Essentially Impossible
Host rearing duration
Ghost moth larvae require 3–5 years in wild conditions. Even under optimal laboratory conditions, the larval period cannot reliably be reduced below approximately 1 year — making any fruiting body operation extremely capital-intensive.
Catastrophic contamination
In experimental settings at the Chinese Academy of Sciences, 85.92% of ghost moth cadavers in cultivation trials were killed by competing entomopathogen Paecilomyces farinosus, not by O. sinensis. Additional competitors included Beauveria bassiana (2.11%) and Penicillium spp. (11.27%). Maintaining a sterile Thitarodes population over more than one year is extremely difficult.
Unknown infection mechanism
Which propagule (conidia, ascospores, or blastospores) infects Thitarodes larvae effectively at low concentration, and by what route, remains unclear. GFP-labeled infection studies map the timeline, but infection rates under artificial conditions are consistently poor compared to natural field rates.
No replicable published protocol
Several Chinese institutions have reportedly achieved indoor fruiting body production at limited scale, but no peer-reviewed protocol with sufficient detail for independent replication has been published. Economic interests drive secrecy. A 2017 US patent (US20170067011A1) claims fruiting body production on sterile rice medium at 9–13°C for 40–60 days, but this has not been independently validated.
What Agar and Liquid Culture Can Achieve
The mycelial stage of O. sinensis — identified as the Hirsutella sinensis anamorph — can be cultured on agar and in liquid media. Colony morphology is white to cream, compact, and very slow-growing (approximately 0.5–1 mm/day at optimal 16–20°C). The fungus will not grow at 30°C or above — its cold-temperature preference reflects adaptation to the alpine environment and is a useful diagnostic feature.
The CS4 strain (Samsoniella hepiali) behaves differently in liquid fermentation. It is the basis of commercial-scale production of adenosine-rich mycelial biomass, and its culture conditions are well-characterized:
About the Out-Grow CS4 Liquid Culture
Out-Grow's liquid culture for this species contains the CS4 strain — commercially identified as Samsoniella hepiali, formerly Paecilomyces hepiali. This is the exact strain behind essentially all peer-reviewed Cordyceps sinensis clinical research, including the Jinshuibao and Bailing capsule trials. It is used for mycelial biomass production, adenosine-rich fermentation, agar expansion and colonization studies, and as a research-grade source of polysaccharides. It will not produce O. sinensis fruiting bodies on substrate inoculation, as no validated protocol for that exists. For fruiting body research involving a caterpillar host, a blastospore suspension protocol is used in experimental settings at low infection rates.
More information: out-grow.com/products/cordyceps-sinensis-cs4
What Bioactive Compounds Does Cordyceps Sinensis (Ophiocordyceps sinensis) Contain?
The chemistry of O. sinensis is best understood in three distinct categories: wild fruiting body specimens, cultivated H. sinensis mycelium, and CS4/S. hepiali fermentation products. These three sources differ significantly in compound profiles. Claims made for one do not automatically transfer to another.
Primary nucleoside quality marker for O. sinensis. Content is higher in cultivated CS4 than in wild specimens, and higher than in cultivated C. militaris. Serves as the regulatory biomarker in the Chinese Pharmacopoeia standard for CS4 products. Target: >2.0 mg/g in CS4 biomass.
Not a primary compound of O. sinensis or CS4. Cordycepin is the signature nucleoside of Cordyceps militaris, which contains up to 90× more cordycepin than wild O. sinensis. Cordycepin is very low to undetectable in CS4 by HPLC. Any marketing claim attributing significant cordycepin to O. sinensis products should be verified by independent CoA.
Complex mixture including EPSF (exopolysaccharide fraction), APS (acid polysaccharide), CPS-1, CPS-2, NCSP-50, cordyglucans, and CS-F10. Immunostimulation is bidirectional: at 25–50 μg/mL lymphocyte proliferation is promoted; above 50 μg/mL effects transition to inhibition. Antitumor activity correlates with MW above 16,000 Da. All antitumor data is animal model only.
Reported as the highest-content nucleoside across natural and cultivated specimens in multiple investigations. Additional nucleosides identified include inosine, cytidine, uridine, thymidine, hypoxanthine, and nucleotides UMP, AMP, and GMP.
Primary fungal sterol; vitamin D₂ precursor. Weak cytotoxicity against HL-60 and BEL-7402 cell lines reported. Moderate antimicrobial activity against E. aerogenes, P. aeruginosa, and C. albicans in vitro.
GC-MS study of Jinshuibao capsules identified massoia lactone (5,6-dihydro-6-pentyl-2H-pyran-2-one) as the dominant volatile compound, alongside palmitic acid and linoleic acid as major fatty acids. This profile is specific to the CS4 fermentation product.
Is Cordyceps Sinensis (Ophiocordyceps sinensis) Safe to Eat?
The cultivated CS4 product has an established safety record from clinical use in China. No acute toxic compounds have been isolated from CS4/S. hepiali mycelium. Clinical trials involving hundreds of participants report no severe adverse events at standard doses. However, the safety picture for wild specimens is significantly different.
Drug Interactions
| Drug Class | Mechanism | Risk Level |
|---|---|---|
| Anticoagulants (warfarin, heparin, aspirin) | Cordyceps may inhibit platelet aggregation; additive bleeding risk | Moderate — caution required |
| Antidiabetic drugs (insulin, metformin, sulfonylureas) | Cordyceps shows hypoglycemic activity; additive hypoglycemia risk | Moderate — monitor blood glucose |
| Immunosuppressants (cyclophosphamide, calcineurin inhibitors) | Cordyceps upregulates immune function, potentially counteracting immunosuppression | Moderate — contraindicated post-transplant |
Most drug interaction data is from in vitro or animal studies. Clinical significance has not been validated in human pharmacokinetic studies. Interactions should be treated as theoretical but plausible. Avoid in pregnancy and breastfeeding: insufficient safety data.
What Makes Cordyceps Sinensis (Ophiocordyceps sinensis) Remarkable?
The Genome Is Mostly Junk — By Design
At ~110.8 Mb, O. sinensis has one of the largest genomes in the Ascomycota, yet encodes only 8,916 protein-coding genes — comparable to small-genome fungi. The explanation: 81.5% of the genome consists of repetitive sequences, 88.1% of which are retrotransposons distributed mutually exclusively from gene regions. This suggests active silencing by RIP (repeat-induced point mutation) and DNA methylation — likely driven by long periods of geographic isolation on the Tibetan Plateau where clonal reproduction allowed transposon proliferation that was later silenced. The mitochondrial genome, at 157,539 bp, is the fourth largest Ascomycota mt genome ever sequenced, with 49.25% repetitive content. Why this cold-adapted pathogen needs such an elaborated mt genome is unknown.
Behavioral Manipulation Without Brain Invasion
Infected Thitarodes larvae migrate toward the soil surface and orient head-upward before dying — positioning that facilitates stroma emergence and spore dispersal. A 2024 study demonstrated this correlates with dramatically reduced acetylcholine (ACh) levels in larval brains, caused by aberrant acetylcholinesterase activity driven by fungal chemical signals — not by direct fungal invasion of neural tissue. Caspofungin (an antifungal drug) blocked both mummification and the AChE aberration, directly linking the infection to the behavior via a cholinergic mechanism. This is molecularly distinct from the ant-manipulating Ophiocordyceps species, which appear to use secreted proteins and circadian rhythm disruption rather than targeting acetylcholine.
The Multi-Microorganism Complex Hypothesis
Wild C. sinensis specimens are not single-organism objects. Alongside dominant O. sinensis, specimens consistently harbor Samsoniella hepiali (the CS4 commercial strain) in the stroma and ascospores, multiple GC-biased and AT-biased O. sinensis genotypes, an endofungal bacterial community dominated by Proteobacteria, Acidobacteria, and Actinobacteria, and more than 30 other associated filamentous fungal species. Some researchers propose wild C. sinensis should be understood as a "microecosystem" — a consortium of organisms whose collective chemistry may not be reproducible by any single purified strain including CS4.
A Fungal Strain Under an Assumed Name
The strain used in virtually all O. sinensis-labeled clinical trials and supplements worldwide (CS4) was isolated decades ago, approved in China as Paecilomyces hepiali, and is now classified as Samsoniella hepiali — a fungus in a different family entirely. This means that most of what is sold as a "Cordyceps sinensis" supplement globally is derived from an organism more closely related to Beauveria than to Ophiocordyceps. Bioactive compounds overlap sufficiently in adenosine and polysaccharide content that clinical outcomes probably translate — but cordycepin, sterol profiles, and minor metabolites differ. This is arguably the most significant species misrepresentation in the functional mushroom supplement industry.
The Most Expensive Fungus in History
At 2015 peak prices above $60,000/kg, O. sinensis traded at a higher value per kilogram than gold. Between 2000 and 2015 the price increased approximately 10-fold, driven by rising Chinese middle-class demand for luxury health goods and declining wild harvest yields. Yartsa gunbu harvest accounts for roughly 40% of rural cash income in the Tibet Autonomous Region, with entire villages undertaking seasonal migration to high-altitude collection grounds. In Bhutan, auction prices have reached the equivalent of ~$26,520 USD/kg. No other fungal species has had a comparable economic impact on a human population.
The Last of Us — But Not Quite
The HBO series and video game The Last of Us explicitly credits Ophiocordyceps as the inspiration for its zombie-fungus premise. However, the ant-manipulating species most relevant to that fiction are O. unilateralis and related species infecting carpenter ants in tropical forests — not O. sinensis, which infects underground caterpillars in alpine tundra. The cultural connection nonetheless exists, and the 2024 discovery of the cholinergic mechanism in caterpillar behavioral manipulation drew on exactly the kind of public awareness the show created.
Also available as a culture plate from Out-Grow.
Cordyceps Sinensis (Ophiocordyceps sinensis) Liquid CultureFrequently Asked Questions About Cordyceps Sinensis (Ophiocordyceps sinensis)
What is the difference between Cordyceps sinensis and Cordyceps militaris?
Cordyceps sinensis (correctly Ophiocordyceps sinensis) and Cordyceps militaris are distinct species in different families with significantly different biology, host ranges, and chemistry. O. sinensis is characterized by dark brown-to-black stroma, infection of high-altitude Thitarodes caterpillar larvae, and adenosine as its primary nucleoside biomarker. C. militaris produces bright orange fruiting bodies, infects moth and butterfly pupae at lower elevations, and contains up to 90 times more cordycepin (3′-deoxyadenosine) than O. sinensis. C. militaris can be commercially cultivated on grain substrate and is fully different from the CS4 strain sold under the C. sinensis name. Both are sold in the supplement market as "Cordyceps" with limited species transparency.
What is CS4 and why does it appear on Cordyceps sinensis products?
CS4 is the designation for a strain originally isolated from wild Ophiocordyceps sinensis material, classified as Paecilomyces hepiali in 1985 and reclassified as Samsoniella hepiali in 2020. It is not O. sinensis — it sits in a different family (Cordycipitaceae, not Ophiocordycipitaceae). CS4 is used commercially because it can be fermented at scale, produces adenosine-rich mycelial biomass, and is the basis for virtually all peer-reviewed clinical research on "Cordyceps sinensis." The chemical profiles overlap significantly in adenosine and polysaccharide content, but cordycepin is absent in CS4 and sterol profiles differ. When a product says "Cs-4" or "CS-4," it contains S. hepiali.
Can Cordyceps sinensis be grown at home?
The mycelial anamorph (Hirsutella sinensis) can be maintained on agar or expanded in liquid culture at home lab scale, given the fungus's cold-temperature preference (16–20°C optimal) and slow growth rate. However, producing the complete specimen — sclerotium plus stroma — requires a living ghost moth larva that has been infected by the fungus, which involves host-rearing challenges that make this effectively impossible outside specialized research facilities. The CS4/S. hepiali strain in liquid culture is the practical alternative for mycelial biomass and compound production; it grows at standard fermentation temperatures (24–28°C) and does not require an insect host.
Is wild Cordyceps sinensis safe to consume?
Wild O. sinensis presents a documented arsenic contamination risk. Tested specimens average approximately 8.85 μg/g arsenic — far above China's 2.0 ppm Pharmacopoeia limit for herbal medicines. This is why China's regulatory authority banned wild O. sinensis as a food additive and health food ingredient in 2016. Risk analysis suggests concern for consumption beyond 90 days. Cultivated CS4 products (Jinshuibao, Bailing capsules) are produced in controlled fermentation with no soil contact and have a substantially better safety profile with no documented severe adverse events in clinical trials. If purchasing wild specimens, verified heavy metal testing is essential.
Does Cordyceps sinensis really contain cordycepin?
No, not in significant quantities. Cordycepin (3′-deoxyadenosine) is very low to undetectable in both wild O. sinensis and CS4/S. hepiali fermentation products by HPLC analysis. Cordycepin is the signature nucleoside of Cordyceps militaris, which produces it in quantities up to 90 times higher than O. sinensis. Marketing claims attributing significant cordycepin content to O. sinensis-labeled products should be treated with skepticism and verified by independent certificate of analysis. Adenosine — not cordycepin — is the primary nucleoside biomarker and quality indicator for genuine CS4 products.
What does the research actually show about Cordyceps sinensis health effects?
The most methodologically sound human evidence involves CS4 products, not wild specimens. Positive signals include a well-designed randomized controlled trial showing statistically significant improvements in fatigue and respiratory symptoms in long COVID patients taking Jinshuibao, and a controlled study showing improved exercise performance in elderly volunteers. Multiple meta-analyses of CS4 as an adjuvant for chronic kidney disease show consistent directional benefit, though the Cochrane review rated overall evidence quality as low due to risk of bias and methodological variability. No FDA Phase III trials exist. No controlled human oncology trials exist — all antitumor data remains at in vitro and animal model level. The 1994 report of Chinese athletes breaking world records after CS4 use drove initial Western interest but has never been replicated under controlled conditions.